SCHEMBL2163736

SCHEMBL2163736

CC(C)(C)c1ccccc1[SiH](OCCCCC(=O)O)c1ccccc1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RBP4 P02753 2/20 0.39
NPSR1 Q6W5P4 1/20 0.38
PPARA Q07869 4/20 0.38
ALDH1A1 P00352 5/20 0.38
KDM4E B2RXH2 2/20 0.38
GAA P10253 2/20 0.38
FFAR4 Q5NUL3 1/20 0.36
RXRA P19793 1/20 0.35
RXRB P28702 1/20 0.35
RXRG P48443 1/20 0.35
LTB4R Q15722 2/20 0.35
LTB4R2 Q9NPC1 1/20 0.35
MAPT P10636 1/20 0.35
RXFP1 Q9HBX9 1/20 0.35
HDAC3 O15379 1/20 0.35
HDAC4 P56524 1/20 0.35
HDAC1 Q13547 1/20 0.35
HDAC7 Q8WUI4 1/20 0.35
HDAC2 Q92769 1/20 0.35
HDAC10 Q969S8 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3295364 0.72 ALDH1A1 (0.38) NPSR1ALDH1A1KDM4EGAARXRA
SCHEMBL8931196 0.70 ALDH1A1 (0.35) ALDH1A1KDM4EGAARXRARXRB
SCHEMBL30434458 0.69 ALDH1A1 (0.35) PPARAALDH1A1KDM4EGAARXRA
SCHEMBL706844 0.68 RIPK1 (0.35) PPARA
SCHEMBL28634307 0.67 ALDH1A1 (0.49) RBP4NPSR1ALDH1A1KDM4EGAA
SCHEMBL9698448 0.67 LTB4R (0.47) NPSR1PPARAALDH1A1KDM4EGAA
SCHEMBL7910681 0.66 LTA4H (0.46) ALDH1A1MAPTHDAC6
SCHEMBL864473 0.65 LTA4H (0.47) ALDH1A1HPGD
SCHEMBL3298464 0.65 ALDH1A1 (0.43) NPSR1ALDH1A1KDM4EGAARXRA
Propionic Acid SCHEMBL28419513 0.65 ALDH1A1 (0.48) RBP4NPSR1ALDH1A1KDM4EGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2228376-B1 PYRIPYROPENE DERIVATIVE HAVING ACAT2-INHIBITING ACTIVITY KITASATO INST (JP) 2015-06-03 EP disclosed
US-8519128-B2 Pyripyropene derivatives having an ACAT2-inhibiting activity THE KITASATO INSTITUTE (JP) 2013-08-27 US disclosed
US-20110184173-A1 Pyripyropene Derivatives Having An ACAT2-Inhibiting Activity THE KITASATO INSTITUTE (JP) 2011-07-28 US disclosed
EP-2228376-A1 PYRIPYROPENE DERIVATIVE HAVING ACAT2-INHIBITING ACTIVITY The Kitasato Institute (JP) 2010-09-15 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110184173-A1 Pyripyropene Derivatives Having An ACAT2-Inhibiting Activity ACAT2, ACAT1, AGPAT2 RBP4 768/4885NPSR1 3321/4885PPARA 103/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.